In Vitro Susceptibilities of Clinical Yeast Isolates to the New Antifungal Eberconazole Compared with Their Susceptibilities to Clotrimazole and Ketoconazole

The antifungal activity of eberconazole, a new imidazole derivative, against 124 clinical isolates of Candida comprising eight different species and to 34 isolates of Cryptococcus neoformans was compared to those of clotrimazole and ketoconazole. MICs of eberconazole, determined by the National Comm...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Torres-Rodríguez, Josep M., Mendez, Raúl, López-Jodra, Olga, Morera, Yolanda, Espasa, Mateu, Jimenez, Teresa, Lagunas, Carme
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Microbiology 1999
Предметы:
Susceptibility
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC89253/
https://ncbi.nlm.nih.gov/pubmed/10223946
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы